(Q53850227)

English

Receptor for advanced glycation end products is a promising target of diabetic nephropathy.

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Receptor for advanced glycation end products is a promising target of diabetic nephropathy. (English)

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

author name string

Yasuhiko Yamamoto

1

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Toshio Doi

2

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Ichiro Kato

3

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Harumichi Shinohara

4

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Shigeru Sakurai

5

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Hideto Yonekura

6

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Takuo Watanabe

7

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Kihn Mar Myint

8

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Ai Harashima

9

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Masayoshi Takeuchi

10

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Shin Takasawa

11

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Hiroshi Okamoto

12

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Noriyoshi Hashimoto

13

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Masahide Asano

14

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Hiroshi Yamamoto

15

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

1043

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

562-566

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.064

21 January 2018

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.064

21 January 2018

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.064

21 January 2018

Identifiers

10.1196/ANNALS.1333.064

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/16037279

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53850227&oldid=1235920710"